• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Reducing the Risk of Comparator Sourcing

    Clinical Data Management

    Leveraging AI/ML Analytics for Better Clinical Development Decisions

    What is a Manufacturing Ecosystem and Why are They Growing?

    Get Smart: Integrating PAT Data into Existing Biotech Data Infrastructures
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility

    JSR Life Sciences Consolidates KBI Biopharma and Selexis SA

    Charles River, Wheeler Bio Partner to Operate RightSource Laboratory

    Cellular Origins Launches Robotic Platform for Scalable Manufacture of Advanced Therapies

    Waters Corp. Acquires Light Scattering Company Wyatt Technology
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Manufacturing Complex Peptide APIs

    How CDMOs Can Leverage Contract Terms to Facilitate Payment

    Purification – A Bottleneck for Large-Scale Manufacturing of Oligonucleotide API?

    Peptide Aggregation - A Complex Topic

    Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Traceability & 2D Barcodes

    Complex in Complex – New Hopes for Better Drug Delivery in Topical Dosage Formulation

    Proactive Resource Group Offers DSCSA Services for Pharma Companies

    Catalent Adds New Cryogenic Capabilities at Japanese Facility

    TraceLink, PharmaLink Partner to Simplify DSCSA Compliance
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Manufacturing Complex Peptide APIs

    How CDMOs Can Leverage Contract Terms to Facilitate Payment

    Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility

    JSR Life Sciences Consolidates KBI Biopharma and Selexis SA

    Charles River, Wheeler Bio Partner to Operate RightSource Laboratory
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Purification – A Bottleneck for Large-Scale Manufacturing of Oligonucleotide API?

    FDA 2023 Inspection Roadmap: Is “Readiness” in Your Annual Objectives?

    FDA Watch: Are You Suitably Staffed?

    FDA Watch: Is Your Supply Chain at Risk?

    FDA Watch: CDER to Launch Guidance Snapshot Pilot Program
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Quotient Sciences

    Federal Equipment Company

    U.S. Pharmacopeia (USP)

    CMC Pharmaceuticals

    Lannett CDMO
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Quotient Sciences

    Federal Equipment Company

    U.S. Pharmacopeia (USP)

    CMC Pharmaceuticals

    Lannett CDMO
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    API Sourcing Trends

    Ed Price of PCI Synthesis addresses trends, regulatory and supply chain hurdles, and quality concerns

    API Sourcing Trends
    Ed Price of PCI Synthesis
    Kristin Brooks, Contract Pharma03.19.15
    Globalization in the pharma and biopharma industry has contributed to an increasingly complex supply chain fraught with numerous challenges. And, outsourcing to emerging markets of India and China, for example, have led to increased regulatory scrutiny following numerous incidents of contaminated raw materials. Since then, APIs sourced from these, and other countries, have been subject to increased testing and regulatory inspections. Today, concerns about the supply chain and drug quality persist.
     
    PCI Synthesis, a manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products, based in the greater Boston area, provides a domestic perspective.Contract Pharma spoke with Ed Price, the company’s president and chief executive officer, to discuss the latest API sourcing trends, regulatory and supply chain hurdles, and quality concerns. -KB
     
    Contract Pharma: What trends are you seeing with respect to API sourcing?
     
    Ed Price: Increasingly we see companies less interested in outsourcing to places like China and India. Companies that hoped to save their way to success have discovered they can save money overseas but they can’t guarantee they will get the right results. The FDA has heightened its level of regulatory scrutiny, holding overseas manufacturers to the same standards as those enforced in the U.S. But that will take time.
     
    Meanwhile, time zone hurdles, delivery timetables, occasional language barriers and the like, just make it more difficult for these companies to outsource overseas. By turning to a local manufacturer, they have the ability to forge a personal relationship, their issues can be addressed quickly, and they have the opportunity to closely monitor the quality of manufacturing on a continuous basis.

    CP: What types of product do you see an increased demand for? 

    EP: There is a steady demand for the manufacture of active ingredients, which is great for companies like PCI Synthesis, which specializes in this area. We also see a steady flow of new opportunities from smaller, virtual companies.
     
    CP: What are some of the main challenges clients approach PCI with?
     
    EP: Many clients who approach us have come to realize that their technology is not as advanced as they thought it was for clinical development. They are surprised at the level of investment, time and resources needed to get ready.
     
    CP: As a domestic supplier, how have continued challenges with India and China impacted your business?
     
    EP: Drugs or raw ingredients that come from overseas and found to be subpar hurt the entire industry. American consumers need to have faith that the medicines they are taking or giving to their children are of high quality and at the dosage their doctors’ recommend. 
     
    We’ve heard horror stories from our clients about their experiences overseas. Many of them have learned that lesson the hard way. When they work with us, we see first-hand how our culture, project management and quality products have a positive impact on them, their business and our business. As their contract manufacturer, we continually evaluate what we need to do to help our clients most effectively, independent of where they have been or where they might go in the future.
     
    CP: What do you anticipate in the near term as far as any progress in these regions? 
     
    EP: The FDA’s site inspections and increased scrutiny, coupled with oversees manufacturers’ improved adherence and compliance to the FDA’s regulations, will ultimately help the industry and the American public. But it is a slow road to travel, and it will be patchwork progress for a long while.
     
    CP: What are the major supply chain hurdles experienced today? How can they be overcome?
     
    EP: There is definitely a seasonal angle to supply chain hurdles. As all of us in the Northeast can probably tell you, the historic winter of 2015 impacted the supply chain in ways we had not seen before. Delivery delays were felt at every point in the supply chain. For PCI, for example, that translated in delays in raw materials that fortunately we were able to address in our production schedules. We were able to continue to deliver the high quality active ingredients and excellent service our clients expect of us because we were on top of the situation and communicated regularly and immediately with our clients. But the weather-induced delays wreaked havoc for other vendors, and for many it was a real struggle.
     
    Even when a hurdle is not tied to bad weather, delivery date slippage is a very real concern, particularly when the goods are coming from overseas. It takes a lot more work to manage those delivery delays when dealing with overseas suppliers; you don’t always get to the root of the real cause of the delays. Whether it is corruption, bad business models, inexperienced staff or something else, delays from overseas suppliers are just more challenging to deal with than delays you may find from U.S. suppliers.
     
    CP: How do you avoid interruptions, unexpected expenses, and quality control issues?
     
    EP: Every CMO can make its case on paper; but it is in the finer things – the day-to-day details – where a CMO really shows its value. We find that the project manager not only has to excel at delivering “the goods” but also has to ensure expectations are met and communication is effective and timely throughout the project lifecycle. Transparency, predictability and even chemistry all play a part in it. It’s important to always have a plan and a backup plan to avoid delays and interruptions, but more importantly, to keep customers in the loop at every stage, and have solid recommendations for any hurdles that we face. 
     
    CP: How do you help clients navigate increased legal and regulatory hurdles?
     
    EP: Staying on top of details is important in this business. But with increased competition, global outsourcing, higher levels of compliance and increasing regulation, those details are more complex than ever in this industry. You have to stay on top of what is coming down from the FDA, but also act immediately rather than defer until a later date. Also, it’s imperative to have ongoing, effective communication with our clients. We advise them on what the FDA is looking for and steer them in the right direction using our experience and best practices. The whole industry is very dynamic, and every company needs to be closely in tune to respond appropriately.
     
     
    Edward S. Price is a founding member of the New England CRO/CMO Council and the president of PCI, a 16-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products. He can be reached at Ed.Price@pcisynthesis.com.


    Kristin Brooks has been associate editor at Contract Pharma since 2004.
    Related Searches
    • Outsourcing
    • contract pharma
    • API
    • Biopharma
    Suggested For You
    CPhI North America Event Info CPhI North America Event Info
    Seqens Innovative & Generic Pharmaceuticals (I&GP) North America Seqens Innovative & Generic Pharmaceuticals (I&GP) North America
    Aprecia Names Owen Murray as Its CEO Aprecia Names Owen Murray as Its CEO
    PCI Synthesis PCI Synthesis
    Tower Cold Chain to Open New Global Headquarters in the UK Tower Cold Chain to Open New Global Headquarters in the UK
    Aurion Biotech Makes Strategic Investments in Manufacturing Aurion Biotech Makes Strategic Investments in Manufacturing
    Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies
    Emergent BioSolutions, Providence Therapeutics Enter Vaccine Manufacturing Partnership Emergent BioSolutions, Providence Therapeutics Enter Vaccine Manufacturing Partnership
    Trust, but Verify Trust, but Verify
    Planning For Better Clinical Trials Planning For Better Clinical Trials
    Raman Spectroscopy for Pharmaceutical Analysis & Quality Control Raman Spectroscopy for Pharmaceutical Analysis & Quality Control
    Inhaled Drug Delivery Trends Inhaled Drug Delivery Trends
    Clinical Trial Kitting Clinical Trial Kitting
    Maintaining Critical Drug Supply During COVID-19 Maintaining Critical Drug Supply During COVID-19
    Partnering with a CDMO for Orphan Drug Development Partnering with a CDMO for Orphan Drug Development

    Related Live From Shows

    • CPhI North America Event Info

      CPhI North America Event Info

      ...
      04.13.23

    • Seqens Innovative & Generic Pharmaceuticals (I&GP) North America

      ...
      Norman Birnbach, PR for Seqens Innovative & Generic Pharmaceuticals (I&GP) North America 02.15.23

    • Breaking News | Industry News | Promotions & Moves
      Aprecia Names Owen Murray as Its CEO

      Aprecia Names Owen Murray as Its CEO

      Most recently served in VP role at Recordati Rare Diseases.
      02.01.23


    • PCI Synthesis

      ...
      Norman Birnbach, PR for PCI Synthesis 10.05.21

    • Breaking News | Cold Chain Management | Facilities | Industry News | Packaging & Tracking
      Tower Cold Chain to Open New Global Headquarters in the UK

      Tower Cold Chain to Open New Global Headquarters in the UK

      The 26,000 sq. ft building will greatly expand Tower’s container conditioning and storage capacities.
      09.16.21

    Loading, Please Wait..
    Trending
    • Aurigene Expands Biologics CDMO Capacity
    • Astellas To Transfer Manufacturing Plant To Delpharm
    • Catalent Adds New Cryogenic Capabilities At Japanese Facility
    • Thermo Fisher Expands Steriles Facility In Asia-Pacific Region
    • Lifecore Biomedical Enters Into $150M New Financing Deal
    Breaking News
    • AVROBIO Sells Cystinosis Gene Therapy for $87.5 Million
    • Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility
    • JSR Life Sciences Consolidates KBI Biopharma and Selexis SA
    • Charles River, Wheeler Bio Partner to Operate RightSource Laboratory
    • Cellular Origins Launches Robotic Platform for Scalable Manufacture of Advanced Therapies
    View Breaking News >
    CURRENT ISSUE

    May 2023

    • New Modalities Hog the Limelight
    • Cell and Gene Therapy is Coming of Age
    • Demand Surges for Cell and Gene Therapy Contract Manufacturing
    • Embracing a New Reality
    • Japan: A Unique Opportunity for Regenerative Medicines and Cell & Gene Therapies
    • Single-Use Technologies Enable Biologic Scaling
    • Get Smart: Integrating PAT Data into Existing Biotech Data Infrastructures
    • FTEs in Drug Discovery
    • Digital Transformation in Pharma
    • What is a Manufacturing Ecosystem and Why are They Growing?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Verdure Sciences Receives Award for Sustainable, Ethical Turmeric Sourcing
    BGG Receives Patent for Saw Palmetto ID Method
    Premium Label & Packaging Solutions Receives Safe Quality Food (SQF) Certification
    Coatings World

    Latest Breaking News From Coatings World

    Boeing Starts Construction on New St. Louis Facility
    Brand Finance: Post-COVID Recovery Slows for Chemicals Industry Battling Energy Crisis
    BCF Calls for Greater Urgency on REACH Impasse
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CareDx, Miromatrix Collaborate on Bioengineered Organs Research
    Capitainer Releases to Market its Fully Automated Sample Handler
    Titan Medical Licenses Most IP to Intuitive; CEO Steps Down
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility
    JSR Life Sciences Consolidates KBI Biopharma and Selexis SA
    Charles River, Wheeler Bio Partner to Operate RightSource Laboratory
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Beautycounter Names New Interim CEO
    Shaz & Kiks Available at Sephora
    Stetson Introduces Men’s Grooming Portfolio
    Happi

    Latest Breaking News From Happi

    Shaz and Kiks Launches at Sephora
    Beautycounter Appoints Board Director Mindy Mackenzie Interim CEO
    Unilever Ventures’ Backs Selva Ventures in $34 Million Fund for Early-Stage CPG Brands
    Ink World

    Latest Breaking News From Ink World

    ACTEGA, Makro Labelling to Advance Signite Technology
    BCF Requests Greater Urgency on REACH Impasse
    Updated Method Published for Entire BASF Product Portfolio
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    ACTEGA teams with Makro Labelling to advance Signite technology
    Constantia Flexibles and SB Packagings commence joint venture
    Inland donates new VersaStudio printer to local high school
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Mann+Hummel Names President Air Filtration Americas
    KNH Launches Eco-Friendly Menstrual Pads
    Niine Introduces India's First PLA-Based Sanitary Pads
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Enrollment Completed in Anika Therapeutics' Hyalofast Study
    Exactech Releases Next-Gen GPS Shoulder
    Data Shows Favorable Survivorship of MISHA Knee System & Reduction of Arthroplasty Risk in Patients
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    onsemi Presents Path to Accelerate Revenue Growth
    STMicroelectronics Introduces Waterproof MEMS Pressure Sensor
    Graphene Flagship to Join Euro Nano Forum 2023

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login